| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 06/13/2022 | 426.11% | ThinkEquity | → $4 | Initiates Coverage On | → Buy |
| 04/12/2021 | 886.45% | Zacks Investment Research | → $7.5 | Initiates Coverage On | → Not Rated |
| 09/21/2020 | 1346.8% | HC Wainwright & Co. | $25 → $11 | Maintains | Buy |
Tiziana Life Sciences Questions & Answers
The latest price target for Tiziana Life Sciences (NASDAQ: TLSA) was reported by ThinkEquity on June 13, 2022. The analyst firm set a price target for $4.00 expecting TLSA to rise to within 12 months (a possible 426.11% upside). 1 analyst firms have reported ratings in the last year.
The latest analyst rating for Tiziana Life Sciences (NASDAQ: TLSA) was provided by ThinkEquity, and Tiziana Life Sciences initiated their buy rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Tiziana Life Sciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Tiziana Life Sciences was filed on June 13, 2022 so you should expect the next rating to be made available sometime around June 13, 2023.
While ratings are subjective and will change, the latest Tiziana Life Sciences (TLSA) rating was a initiated with a price target of $0.00 to $4.00. The current price Tiziana Life Sciences (TLSA) is trading at is $0.76, which is within the analyst's predicted range.